Clinical Trials Browser

Neoplasms × Bortezomib × Other hematologic neoplasm × Clear all

NCT01062230 2015-04-06

Bone Effect of Bortezomib in Patients With Relapsed/Refractory Multiple Myeloma

Phase 2 Terminated

6 enrolled 4 charts

Other hematologic neoplasmPlasma cell

Multiple Myeloma, Neoplasms, Hematologic Neoplasms